Afuco™ Anti-Human Integrin αvβ5 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-Integrin αvβ5 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a function-blocking antibody against the integrin αvβ5 prevented development of lung vascular permeability in two different models of acute lung injury (ALI). The integrin αvβ5 can used as a central regulator of increased pulmonary vascular permeability and a potentially attractive therapeutic target in ALI.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-430CL |
| Pricing | Inquiry |
| Host | Human |
| Target | Integrin αvβ5 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |